{"id":"W2803381821","doi":"10.1007/s00277-018-3365-y","title":"Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial","year":2018,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Novartis","keywords":"Ruxolitinib; Medicine; Hematocrit; Polycythemia vera; Internal medicine; Hematology; Anemia; Myelofibrosis; Surgery; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002583847,0.0006731029,0.001571495,0.0002927467,0.0004234183,0.0009599888,0.0005330014,0.001148512,0.00200661],"category_scores_gemma":[0.001473023,0.0002328211,0.001264662,0.000313323,0.0003133705,0.0006302119,0.000306627,0.002452702,0.0005557219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000427044,"about_ca_system_score_gemma":0.0004306934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004409151,"about_ca_topic_score_gemma":0.001324749,"domain_scores_codex":[0.9994388,0.0002551957,0.00003217536,0.00006415014,0.00007374305,0.0001359061],"domain_scores_gemma":[0.9991319,0.0002044388,0.0002244861,0.0001002982,0.00005760344,0.000281272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6756805,0.02135044,0.0168628,0.001411943,0.003363742,0.0008692744,0.0002721538,0.002891714,0.02586852,0.0005183302,0.01352312,0.2373875],"study_design_scores_gemma":[0.7133426,0.2008985,0.06478245,0.0002563887,0.001762415,0.001183667,0.00007934948,0.003765854,0.003982277,0.0006737454,0.009210967,0.0000618551],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836338,0.008488672,0.0007464989,0.0007468991,0.0001771208,0.001106924,0.001756817,0.0001603879,0.003182877],"genre_scores_gemma":[0.9892824,0.002093398,0.0007922364,0.001401752,0.0001950917,0.001097805,0.002929767,0.0000264641,0.002181152],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002583847,"threshold_uncertainty_score":0.01366484,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1235891608295298,"score_gpt":0.3813806818075789,"score_spread":0.2577915209780491,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}